2024 NCLM | Keep moving forward, meet at the grand event, we will see you again next year

In early autumn, we gather in Hangzhou. The 18th National Academic Conference on Laboratory Medicine of the Chinese Medical Association (2024 NCLM), hosted by the Chinese Medical Association and the Laboratory Medicine Branch of the Chinese Medical Association, and hosted by the Zhejiang Medical Association, will be held in Hangzhou on August 22. The grand opening of the International Expo Center. As the largest academic conference in my country's laboratory science community in 2024, this conference brings together well-known experts and scholars to discuss new developments in clinical testing and laboratory management.

    01 Academic masters, collision of opinions

During the meeting, a number of domestic and foreign front-line testing experts shared their diagnosis and treatment experience and scientific research results in the field of thrombosis and hemostasis diagnosis, and looked forward to a new future in which scientific and technological development assists smart testing, providing a feast of ideas for the participants.

Among them, the "New Coagulation and New Perspectives-Laboratory Examination of Venous Thromboembolism" seminar hosted by Shanghai Sun Biotech was specially invited to host Professor Wang Xuefeng and give the lecture, Professor Wang Mingshan, focusing on the concept and risks of venous thromboembolism (VTE). Factors and laboratory examinations are carried out. Venous thromboembolism (VTE), known as the "silent killer", is characterized by high misdiagnosis rate, high missed diagnosis rate and high mortality rate, and is affected by inherited thrombophilia and acquired risk factors. Early judgment and early diagnosis are key steps to prevent the formation of VTE and prevent medical risks after VTE formation. Laboratory examination is a convenient method.

According to the three factors of VTE formation, VTE laboratory examination items include vascular endothelial injury markers (vWF, TM, t-PAIC), coagulation activation markers (TAT, FVIII:C, FIB), physiological and pathological anticoagulant substances ( AT:A, PC:A, PS:A, LAC), fibrinolytic system project (PLG:A, D-D, FDP, PIC), etc. These examinations all belong to the field of thrombosis and hemostasis diagnosis. Therefore, observing changes in various indicators of related functions in the blood can screen high-risk groups for VTE in various clinical disciplines. It plays an important role in the early diagnosis of VTE and thrombosis risk assessment. At the same time, it can also be used For efficacy observation, medication guidance, and prognosis judgment.

 02 Star products, assembled and unveiled

This inspection event is not only a platform for academic exchanges, but also a display window for clinical products. Shanghai Sun Biotech adheres to the concept of "keep improving and pursue excellence" and brought star products such as UP series, UR series fully automatic coagulation meter, UL-2000LAS fully automatic coagulation line, thrombosis and hemostasis diagnostic reagents and medical consumables to its grand appearance, which were highly praised by experts. widespread attention.

Flexible, efficient, intelligent UL-2000LAS Laboratory Automation System

Shanghai Sun Biotechnology's assembly line is specially built for coagulation testing. It does not simply connect different modules in series, but aims at the pain points of laboratory departments' dual requirements for coagulation testing speed and accurate results, helping customers solve the problems they encounter.

At present, medical institutions with high daily testing volume are faced with problems such as difficulty in improving TAT time, high requirements for accuracy of test results, and space constraints. The UL-2000LAS Laboratory Automation System innovatively integrates highly integrated sample entry and exit, centrifugation, and capping. , track, and analysis modules to solve these problems: seamless direct connection to the UR series fully automatic coagulation analyzer; independent detection channel, super anti-interference ability; standard configuration of fully automatic sample processing system, covering an area of less than 2 square meters.

Constant speed, high speed and stability UR series fully automatic coagulation analyzer

As a constant-speed high-speed coagulation testing instrument, the UR series fully automatic coagulation analyzer has realized the innovative function of constant-speed coagulation testing through the upgrade of instrument hardware, optimization of software, and high matching with the simultaneous development of supporting reagents.

Among them, any of the five coagulation items (PT/APTT/TT/FIB/D-Dimer) of the UR8000 fully automatic coagulation analyzer can reach 900 tests/hour, and the combined five-item test speed reaches 180 samples/hour, significantly shortening TAT. In addition, it also has HIL monitoring and automated APTT correction test functions, and is equipped with a flexible and diverse sampling and reagent intelligent management system, which can meet the needs of clinical high-throughput coagulation testing and make coagulation testing worry-free.

In addition, the UP series of fully automatic coagulation analyzers, coagulation diagnostic reagents, and coagulation medical consumables, which are important products in the coagulation testing solution, were also on display. With their excellent performance and accurate detection capabilities, they have attracted many professionals to stop and have an in-depth understanding of and comminicate.

 03 Interaction at the booth, endless excitement

During the conference, a number of product promotion meetings were held at the Shanghai Sun Biotech booth. The product manager introduced in detail the advantages and performance indicators of the company's coagulation products, which received unanimous praise from the audience. During the in-depth exchanges and discussions, the visiting guests not only spoke highly of the excellent performance of our products, but also expressed strong interest and expectations for future cooperation opportunities. This is also a sign of Shanghai Sun Biotech’s deep involvement in the field of thrombosis and hemostasis diagnosis. More than twenty years of trust and support.

Create products for life. Shanghai Sun Biotech remains true to its original aspirations and continues to innovate. It has been deeply involved in the field of thrombosis and hemostasis diagnosis for 23 years, providing comprehensive coagulation testing solutions to medical institutions at different levels. In the future, the company will continue to adhere to the development path of scientific and technological innovation, adhere to the quality management system, continuously improve the research and development innovation of instruments and reagents, and work hand in hand with the Laboratory Medicine Branch of the Chinese Medical Association to jointly contribute to the development of laboratory science in my country!